Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,950
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,732
Class I recallsReasonable probability of serious health consequences
24,263
Class II recallsTemporary or medically reversible health consequences
2,873
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,071 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,458 recalls have been announced year to date.
  • Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1
Download CSV
Recalls by class
ClassRecalls
Class II24,263
Class I9,732
Class III2,873
Not Yet Classified1

Showing 741–760 of 17,945 recalls

FDA Recall Ongoing Historical recordClass II

darby dental supply, MEPIVACAINE, Mepivacaine HCI 3% (30mg/mL) Injection, [Mepivacaine HCI Injection, USP], packaged in a carton containing 50 single-dose Cartridges, 1.7 mL each, Rx only, Manufactured by Novocol Pharmaceutical of Canada, Inc., NDC 66467-9760-5.

by Novocol Pharmaceutical of Canada, Inc.

Reason
Defective container: cracked/broken cartridges
Published
December 24, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

3% Polocaine DENTAL, Mepivacaine Hydrochloride 3% (30mg/mL) (Mepivacaine HCI Injection, USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-441-16.

by Novocol Pharmaceutical of Canada, Inc.

Reason
Defective container: cracked/broken cartridges
Published
December 24, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lidocaine HCI 2% and Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose Cartridges, 1.7 ml each, Rx only, Manufactured for Patterson Dental Supply, Inc., 1031 Mendota Heights Road, Saint Paul, MN55120, Manufactured by: Novocol Pharmaceutical of Canada, Inc., NDC 50227-1030-5.

by Novocol Pharmaceutical of Canada, Inc.

Reason
Defective container: cracked/broken cartridges
Published
December 24, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

2% Xylocaine DENTAL with Epinephrine 1:100,000 (Lidocaine HCI and Epinephrine Injection USP), packaged in a carton containing 50 single-dose cartridges, 1.7 mL each, Rx only, Manufactured for Dentsply Pharmaceutical, York, PA 17404, by Novocol Pharmaceutical of Canada, Inc., NDC 66312-176-16.

by Novocol Pharmaceutical of Canada, Inc.

Reason
Defective container: cracked/broken cartridges
Published
December 24, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Terminated Historical recordClass II

CELEBRATION HERBALS US

Product
Celebration Herbals Senna Leaf Herbal Tea 24 Teabags, net wt…
Reason
possible salmonella
Published
December 24, 2025
Distribution
Multiple states

View recall →

FDA Recall Ongoing Historical recordClass II

Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.

by Lupin Pharmaceuticals Inc.

Reason
Defective container - seal not adhering to bottles
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-412-02

by Cipla USA, Inc.

Reason
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-411-02

by Cipla USA, Inc.

Reason
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-410-02

by Cipla USA, Inc.

Reason
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Morphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, Manufactured By: /winder Laboratories, LLC, Winder, GA 30680. NDC: 75826-131-01

by Winder Laboratories, LLC

Reason
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Nebivolol Tablets, 20 mg, 90 Tablets, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for Avkare, Pulaski, TN 38478, Product of Italy, NDC 42291-874-90.

by Glenmark Pharmaceuticals Inc., USA

Reason
Cross Contamination with Other Products
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Tropicamide 1%/Cyclopentolate 1%/Phenylephrine 2.5%/Ketorolac 0.5% Topical Ophthalmic Solution, 0.5mL Single-Use Syringe, For Topical Ophthalmic Use Only. Not for IV Use. Fagron Sterile Services, 8710 E 34th St N, Wichita, KS 67226. NDC: 71266-8240-01

by Fagron Compounding Services

Reason
Incorrect Product Formulation
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass III

Varenicline Tablets, 1mg, 56 Tablets, Rx only, Distributor: Dr. Reddy's Laboratories Inc., Princeton, NJ 08540, Made in India, NDC 43598-908-56

by Dr. Reddy's Laboratories, Inc.

Reason
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., (a subsidary of Cipla Ltd) Hauppauge, NY 11786, Manufactured for: Exelan Pharmaceuticals, Inc., Boca Raton, FL 33422, Carton NDC 76282-478-90; Bottle NDC 76282-478-13.

by Cipla USA, Inc.

Reason
Failed stability specifications: Out of specification for hardness test
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals, Inc., Hauppauge, NY 11786, Manufactured for : Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-936-98.

by Cipla USA, Inc.

Reason
Failed stability specifications: Out of specification for hardness test
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall United States Ongoing Historical recordClass I

ByHeart, INC.

Product
1. ByHeart Whole Nutrition Infant Formula cans 24 OZ 680 gra…
Reason
Contaminated with Clostridium botulinum
Published
December 17, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Distributed by: Breckenridge Pharmaceutical Inc., Berkeley Heights, NJ 07922 NDC 51991-748-10.

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Duloxetine Delayed-Release Capsules, USP, 60 mg, 1000-Capsule bottles, Rx Only, Manufactured by: Towa Pharmaceuticals Europe, S.L. Marotrelles, (Barcelona), Spain, Manufactured for : Quallient Pharmaceuticals Health, LLC, Grand Cayman, Cayman Islands, NDC 82009-032-10.

by Breckenridge Pharmaceutical, Inc.

Reason
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Wecare Calasoothe, Net wt. 4 oz (113 g), Manufactured for: Dynarex Corporation, 10 Glenshaw Street, Orangeburg, NY 10962, NDC 67777-234-04.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

FDA Recall Ongoing Historical recordClass II

Globe Zinc Oxide Ointment USP Zinc Oxide 20% Skin Protectant, Net Wt. 2 oz (56.7 g), Distributed by: Trifecta Pharmaceuticals USA 101 NE, Third Avenue, Suite 1500, Ft. Lauderdale, FL 33301, NDC 69396-086-02.

by Blossom Pharmaceuticals

Reason
cGMP deviations
Published
December 10, 2025
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.